Comparison of international consensus guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas

Annals of Surgery

Volumn 254, Issue 6, 2011, Pages 971-976

  Pedrazzoli, Sergio ^a   Sperti, Cosimo ^a   Pasquali, Claudio ^a   Bissoli, Sergio ^b   Chierichetti, Franca ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Castelfranco General Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; FLUORODEOXYGLUCOSE F 18; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; INTERNATIONAL CONSENSUS GUIDELINES; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, PANCREATIC DUCTAL; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; GUIDELINE ADHERENCE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PANCREAS; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 81855227625     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182383137     Document Type: Article

References (49)

1. Ohashi K, Mayakami F, Maruyama M, et al. Four cases of mucous secreting pancreatic cancer. Prog Dig Endosc. 1982;20:348-351.
2. Castillo CF, Adsay VN. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2010;139:708-713.
3. Singh M, MaitraA. Precursor lesions of pancreatic cancer:molecular pathology and clinical implications. Pancreatology. 2007;7:9-19.
4. Sperti C, Pasquali C, Ferronato A, et al. Median pancreatectomy for tumors of the neck and body of the pancreas. J Am Coll Surg. 2000;190:711-716.
5. Warshaw AL. Conservation of the spleen with distal pancreatectomy. Arch Surg. 1988;123:550-553.
6. Beger HG, Krautzberger W, Bittner R, et al. Duodenum-preserving resection of the head of the pancreas in patientswith severe chronic pancreatitis. Surgery. 1985;97:467-473.
7. Takada T, Yasuda H, Uchiyama K, et al. Duodenum-preserving pancreatoduodenostomy. A new technique for complete excision of the head of the pancreas with preservation of biliary and alimentary integrity. Hepato-Gastroenterol. 1993;40:356-359.
8. Takada T. Ventral pancreatectomy: resection of the ventral segment of the pancreas. J Hep Bil Panc Surg. 1993;1:36-40.
9. Thayer SP, Fernandez-del Castillo C, Balcom JH, et al. Complete dorsal pancreatectomy with preservation of the ventral pancreas: a new surgical technique. Surgery. 2002;131:577-580.
10. Nakao A. Pancreatic head resection with segmental duodenectomy and preservation of the gastroduodenal artery. Hepatogastroenterol. 1998;45:533-535.
11. Andersen DK, Topazian MD. Pancreatic head excavation. A variation on the theme of duodenum-preserving pancreatic head resection. Arch Surg. 2004;139:375-379.
12. Sperti C, Polizzi ML, Moro M, et al. Middle-preserving pancreatectomy: an interesting procedure for pancreas-sparing resection. JOP. 2010;11:258-261.
13. Vin Y, Sima CS, Getrajdman GI, et al. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008;207: 490-498.
14. Tanaka M, Chari S, Adsay V, et al. International Consensus Guidelines for management of intraductal papillary mucinous neoplasms andmucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
15. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy?. A study of 147 patients. Am J Gastroenterol. 2007;102: 1759-1764.
16. Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-79.
17. Tang RS, Weinberg B, Dawson DW, et al. Evaluation of the guidelines formanagement of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2008;6:815-819.
18. Pitman MB, Michaels PJ, Deshpande V, et al. Cytological and cyst fluid analysis of small (< or = 3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions. Pancreatology. 2008;8:277-284.
19. Lee CJ, Scheiman J, Anderson MA, et al. Risk of malignancy in resected cystic tumors of the pancreas < or = 3 cm in size: is it safe to observe asymptomatic patients?. A multi-institutional report. J Gastrointest Surg. 2008;12: 234-242.
20. Nagai K, Doi R, Kida A, et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg. 2008;32:271-278.
21. Jang JY, Kim SW, Lee SE, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas:when canwe operate or observe?. Ann Surg Oncol. 2008;15:199-205.
22. Woo SM, Ryu JK, Lee SH, et al. Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patients. Br J Surg. 2009;96: 405-411.
23. Sawhney MS, Al-Bashir S, Cury MS, et al. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas. Clin Gastroenterol Hepatol. 2009;7:1373-1376.
24. Uehara H, Ishikawa O, Ikezawa K, et al. A natural course of main duct intraductal papillary mucinous neoplasm of the pancreas with lower likelihood of malignancy. Pancreas. 2010;39:653-657.
25. Reid-Lombardo KM, Mathis KL, Wood CM, et al. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management. Ann Surg. 2010;251:64-69.
26. Tanno S, Nakano Y, Sugiyama Y, et al. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology. 2010;10:173-178.
27. Sperti C, Bissoli S, Pasquali C, et al. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2007;246: 932-937.
28. Sperti C, Pasquali C, Chierichetti F, et al. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg. 2001;234:675-680.
29. Sperti C, Pasquali C, Decet G, et al. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. J Gastrointest Surg. 2005;9:22-29.
30. Baba T, Yamaguchi T, Ishihara T, et al. Distinguishing benign from malignant intraductal papillary mucinous tumors of the pancreas by imaging techniques. Pancreas. 2004;29:212-217.
31. Shin SH, Han DJ, Park KT, et al. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J Surg. 2010;34:776-783.
32. Bausch D, Mino-Kenudson M, Fernández-Del Castillo C, et al. Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg. 2009;13:1948-1954.
33. Satoh K, Hamada S, Kanno A, et al. Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2010;45:763-770.
34. Shimamoto T, Tani M, Kawai M, et al. MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography. Pancreas. 2010;39:879-883.
35. SerikawaM, Sasaki T, Fujimoto Y, et al. Management of intraductal papillarymucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol. 2006;40:856-862.
36. Wiesenauer CA, Schmidt CM, Cummings OW, et al. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg. 2003;138:610-617.
37. Hirono S, Tani M, Kawai M, et al. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Arch Surg. 2009;144:345-349.
38. Pais SA, Attasaranya S, Leblanc JK, Sherman S, Schmidt CM, DeWitt J. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol. 2007;5:489-495.
39. Hara T, Yamaguchi T, Ishihara T, et al. Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography. Gastroenterology. 2002;122:34-43.
40. Ohno E, Hirooka Y, Itoh A, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009;249:628-634.
41. Maire F, Voitot H, Aubert A, et al. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Am J Gastroenterol. 2008;103:2871-2877.
42. Maker AV, Lee LS, Raut CP, Clancy TE, Swanson RS. Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol. 2008;15:3187-3192.
43. Kawamoto S, Horton KM, Lawler LP, Hruban RH, Fishman EK. Intraductal papillary mucinous neoplasm of the pancreas: can benign lesions be differentiated from malignant lesions with multidetector CT?. Radiographics. 2005;25:1451-1468.
44. Nara S, Onaya H, Hiraoka N, et al. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009;38: 8-16.
45. Ogawa H, Itoh S, Ikeda M, Suzuki K, Naganawa S. Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT. Radiology. 2008;248:876-886.
46. Tomimaru Y, Takeda Y, Tatsumi M, et al. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign andmalignant intraductal papillary-mucinous neoplasm of the pancreas. Oncol Rep. 2010;24:613-620.
47. Correa-Gallego C, Ferrone CR, Thayer SP, et al. Incidental pancreatic cysts: do we really know what we are watching?. Pancreatology. 2010;10: 144-150.
48. Pedrazzoli S, Canton SA, Sperti C. Duodenum-preserving versus pyloruspreserving pancreatic head resection for benign and premalignant lesions. J Hepatobiliary Pancreat Sci. 2011;18:94-102.
49. Nakao A, Fernández-Cruz L. Pancreatic head resection with segmental duodenectomy. Safety and long term results. Ann Surg. 2007;246:923-931.